Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation

Pediatr Int. 2006 Apr;48(2):174-7. doi: 10.1111/j.1442-200X.2006.02192.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aspartate Aminotransferases / blood
  • Bone Marrow Transplantation / adverse effects*
  • Child, Preschool
  • Combined Modality Therapy
  • Erythropoietin / therapeutic use*
  • Female
  • Ferritins / blood
  • Graft vs Host Disease
  • Hemochromatosis / blood
  • Hemochromatosis / therapy*
  • Humans
  • Leukemia, Myeloid, Acute / surgery
  • Liver Function Tests
  • Myelodysplastic Syndromes / surgery
  • Phlebotomy*
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Erythropoietin
  • Ferritins
  • Aspartate Aminotransferases